Janux Therapeutics, Inc. (JANX) Tops Q3 EPS by 22c

Janux Therapeutics, Inc. (NASDAQ: JANX) reported Q3 EPS of ($0.25), $0.22 better than the analyst estimate of ($0.47).

For earnings history and earnings-related data on Janux Therapeutics, Inc. (JANX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Incyte settles CMS lawsuit over Opzelura Medicaid rebate rules
• Playboy to buy back 16.6M shares from Fortress at $1.05 each